Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 31 Aug 2026
- Closes
- 7 Jul 2028, 23:59 UTC
- Value
- USD 499,000
- Reference
- PAR-27-076
- Location
- United States
- Sector
- Healthcare & Pharma
Details
This NOFO encourages applications for the Lasker Clinical Research Scholars Program. The program supports the research activities of clinical researchers during the early stages of their independent careers as they work to improve human health. The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases. In the first phase, Lasker Scholars will receive appointments for up to 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent research budgets. In the second phase, successful scholars will receive up to 3 years of NIH support for their research at an extramural research institute, or can remain as an investigator within the intramural program. Eligibility: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Award range: USD 499000 – 499000
Expected number of awards: 5
CFDA number(s): 93.113
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 411 notices from National Institutes of Health, going back to May 2023 — 383 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 381 open Healthcare & Pharma tenders in United States. This one closes in 649 days.
More from this buyer
- Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)· closes 25 May
- Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)· closes 5 Nov
- NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)· closes 16 Nov
- Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)· closes 10 Nov
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)· closes 10 Nov
Similar Healthcare & Pharma tenders
- Development of monoclonal antibodies to prevent and treat infections from Flaviviruses· closes 13 Apr
- Shaving Kit, Hospital P — 1893 packages, NSN 6530013541156· closes 5 Oct
- Advancing bio-printing of living cells for regenerative medicine· closes 22 Sept
- Development of innovative antimicrobials against pathogens resistant to antimicrobials· closes 13 Apr
- Development of cell-free protein synthesis platforms for discovery and/or production of biologicals· closes 13 Apr
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Supply of Drugs - Ascorbic Acid 500mgHamad Medical Corporation · Qatar
- Procurement of Services for Provision of Seroepidemiological Survey of Vaccine-Preventable Diseases as an integral part of epidemiological surveillanceUNOPS · Uzbekistan
- HIPOCLORITO DE SÓDIO 10% em bombona, destinado ao tratamento de água para consumo humano, com concentração mínima tolerável de 10%, acondicionado em bombonas de 50 a 60 kg, com fornecimento contabilizado por quilograma/unidade, para uso hospitalar e assistência à saúdeEMPRESA BRASILEIRA DE SERVICOS HOSPITALARES - EBSERH · EMPRESA BRASILEIRA DE SERVIÇOS HOSPITALARES · Brazil
- Aquisição de Gás Liquefeito de Petróleo (GLP) para atendimento do Restaurante Estudantil bem como para subsidiar atividades de ensino, pesquisa e extensão nos Laboratórios Educativos de Produção Agroindustrial e de Produção Animal, e de Aulas Práticas e Pesquisas em geral, conforme condições e exigências estabelecidas…INSTITUTO FEDERAL DE EDUCACAO, CIENCIA E TECNOLOGIA GOIANO · INST.FED.DE EDUC., CIENCIA E TEC. GOIANO · Brazil
- Registro de Preços para a aquisição de Produtos para Saúde para Fisioterapia Hospitalar, a fim de atender às necessidades do Hospital Universitário Antônio Pedro (HUAP/UFF), Unidade Gestora (UG) 155915, pertencente à Rede da Empresa Brasileira de Serviços Hospitalares (Rede Ebserh), por um período de 12 (doze) mesesEMPRESA BRASILEIRA DE SERVICOS HOSPITALARES - EBSERH · EBSERH - HOSP. UNIV. ANTONIO PEDRO · Brazil
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →